Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: J. Nelson who wrote (3959)	6/6/1999 6:12:00 PM
From: Lance	Read Replies (2) \| Respond to of 4650

Jim.. I'm holding... I love the technology...I read somewhere about how it works and saw an illustration of it...great application potential, not to mention their part of the BioTech industry. I think it is just a matter of holding a bit longer and we shall see some rewards for that. my opinion......for what it's worth <G> Lance Sims

To: J. Nelson who wrote (3959)	6/6/1999 9:26:00 PM
From: Andrew T	Respond to of 4650

Re: Diagnostic kits for diagnosing pre-cancerous and cancerous conditions of the lung. [ Follow Ups ] [ Post Followup ] [ Welcome To The HealthSeek Healthcare Marketplace ] [ FAQ ] Posted by Rashmi Diagnostics Pvt.Ltd.,25, 23rd Main,J.P.Nagar 2nd Phase,Bangalore-560078,India,Fax : 0091-80-6634435/646520 on December 30, 1998 at 11:13:57: healthseek.com In Reply to: Diagnostic kits for diagnosing pre-cancerous and cancerous conditions of the lung. posted by BioModa, Inc. on September 01, 1998 at 20:57:51: Dear Sirs, We are very keen to market yr line rapid diagnsotics.Pl RUSH information and oblige. Very Best Regards G.R.Rao-Mg.Director : The company is seeking qualified regional distributors for our diagnostic kits. This is technology is 100% accurate, low-cost, easy to use and readily available. This test has the ability to diagnose pre-cancerous conditions od the lung from six to fourteen prior to the development of invasive carcinoma, thereby greatly increasing chances for survival. The company seeks distributors fro all regions of the world. In order to qualify, distributor must have a strong record for quality and integrity of service, strong financials and the ability to deal quickly and effectively with local and regional regulatory agencies. Disrtibutor must be able to show that they have captured a major share of the clinical diagnostics market in their area. Serious inquiries only to: : Ari Ma'ayan : President/CEO : BioModa, Inc. : 8934 Boe Lane NE : Albuquerque, NM 87113 USA : Phone 505 898-1446 : Fax 505 898-1429 : e-mail amaayan@netscape.net : or visit our website at www.biomoda.com